|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar
|
|
2
|
Kamangar F, Dores GM and Anderson WF:
Patterns of cancer incidence, mortality, and prevalence across five
continents: defining priorities to reduce cancer disparities in
different geographic regions of the world. J Clin Oncol.
24:2137–2150. 2006. View Article : Google Scholar
|
|
3
|
Clarke M, Collins R, Davies C, et al:
Tamoxifen for early breast cancer: an overview of the randomised
trials. Early Breast Cancer Trialists’ Collaborative Group
(EBCTCG). Lancet. 351:1451–1467. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Abe O, Abe R, Enomoto K, et al: Effects of
chemotherapy and hormonal therapy for early breast cancer on
recurrence and 15-year survival: an overview of the randomised
trials. Early Breast Cancer Trialists’ Collaborative Group
(EBCTCG). Lancet. 365:1687–1717. 2005.PubMed/NCBI
|
|
5
|
Tokunaga A, Nishi K, Matsukura N, et al:
Estrogen and progesterone receptors in gastric cancer. Cancer.
57:1376–1379. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bianchi F, Hu J, Pelosi G, et al: Lung
cancers detected by screening with spiral computed tomography have
a malignant phenotype when analyzed by cDNA microarray. Clin Cancer
Res. 10:6023–6028. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang N, Zhang J, Shuai L, et al:
Krüppel-like factor 4 negatively regulates β-catenin expression and
inhibits the proliferation, invasion and metastasis of gastric
cancer. Int J Oncol. 40:2038–2048. 2012.
|
|
8
|
Kouzmenko AP, Takeyama K, Ito S, et al:
Wnt/β-catenin and estrogen signaling converge in vivo. J Biol Chem.
279:40255–40258. 2004.
|
|
9
|
Crew KD and Neugut AI: Epidemiology of
gastric cancer. World J Gastroenterol. 12:354–362. 2006.
|
|
10
|
Brenner H, Rothenbacher D and Arndt V:
Epidemiology of stomach cancer. Methods Mol Biol. 472:467–477.
2009. View Article : Google Scholar
|
|
11
|
Parkin D, Whelan S, Ferlay J, Teppo L and
Thomas D: Cancer incidence in five continents. Volume VIII. IARC
Sci Publ. 155:1–781. 2002.PubMed/NCBI
|
|
12
|
Chandanos E and Lagergren J: Oestrogen and
the enigmatic male predominance of gastric cancer. Eur J Cancer.
44:2397–2403. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
La Vecchia C, D’Avanzo B, Franceschi S,
Negri E, Parazzini F and Decarli A: Menstrual and reproductive
factors and gastric-cancer risk in women. Int J Cancer. 59:761–764.
1994.
|
|
14
|
Frise S, Kreiger N, Gallinger S, Tomlinson
G and Cotterchio M: Menstrual and reproductive risk factors and
risk for gastric adenocarcinoma in women: findings from the
Canadian National Enhanced Cancer Surveillance system. Ann
Epidemiol. 16:908–916. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lindblad M, Ye W, Rubio C and Lagergren J:
Estrogen and risk of gastric cancer: a protective effect in a
nationwide cohort study of patients with prostate cancer in Sweden.
Cancer Epidemiol Biomarkers Prev. 13:2203–2207. 2004.PubMed/NCBI
|
|
16
|
Freedman ND, Chow WH, Gao YT, et al:
Menstrual and reproductive factors and gastric cancer risk in a
large prospective study of women. Gut. 56:1671–1677. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Green J, Czanner G, Reeves G, et al:
Menopausal hormone therapy and risk of gastrointestinal cancer:
nested case-control study within a prospective cohort, and
meta-analysis. Int J Cancer. 130:2387–2396. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lindblad M, García Rodríguez LA, Chandanos
E and Lagergren J: Hormone replacement therapy and risks of
oesophageal and gastric adenocarcinomas. Br J Cancer. 94:136–141.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chandanos E, Lindblad M, Jia C, Rubio CA,
Ye W and Lagergren J: Tamoxifen exposure and risk of oesophageal
and gastric adenocarcinoma: a population-based cohort study of
breast cancer patients in Sweden. Br J Cancer. 95:118–122. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chandanos E, Lindblad M, Rubio CA, et al:
Tamoxifen exposure in relation to gastric adenocarcinoma
development. Eur J Cancer. 44:1007–1014. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Harrison JD, Watson S and Morris DL: The
effect of sex hormones and tamoxifen on the growth of human gastric
and colorectal cancer cell lines. Cancer. 63:2148–2151. 1989.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Takano N, Iizuka N, Hazama S, Yoshino S,
Tangoku A and Oka M: Expression of estrogen receptor-α and -β mRNAs
in human gastric cancer. Cancer Lett. 176:129–135. 2002.
|
|
23
|
Furukawa H, Iwanaga T, Koyama H and
Taniguchi H: Effect of sex hormones on carcinogenesis in the
stomachs of rats. Cancer Res. 42:5181–5182. 1982.PubMed/NCBI
|
|
24
|
Campbell-Thompson M, Lauwers GY, Reyher
KK, Cromwell J and Shiverick KT: 17β-estradiol modulates
gastroduodenal preneoplastic alterations in rats exposed to the
carcinogen N-methyl-N′-nitro-nitrosoguanidine.
Endocrinology. 140:4886–4894. 1999.
|
|
25
|
Furukawa H, Iwanaga T, Hiratsuka M, et al:
Suppressive effect of sex hormones on spreading of stomach cancer.
Gan To Kagaku Ryoho. 16:3691–3695. 1989.(In Japanese).
|
|
26
|
Furukawa H, Iwanaga T, Koyama H and
Taniguchi H: Effect of sex hormones on the experimental induction
of cancer in rat stomach - a preliminary study. Digestion.
23:151–155. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Greene GL, Gilna P, Waterfield M, Baker A,
Hort Y and Shine J: Sequence and expression of human estrogen
receptor complementary DNA. Science. 231:1150–1154. 1986.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kuiper GG, Enmark E, Pelto-Huikko M,
Nilsson S and Gustafsson JA: Cloning of a novel estrogen receptor
expressed in rat prostate and ovary. Proc Natl Acad Sci USA.
93:5925–5930. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Green S, Walter P, Kumar V, et al: Human
oestrogen receptor cDNA: sequence, expression and homology to
v-erb-A. Nature. 320:134–139. 1986. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wu CW, Chang YF, Yeh TH, et al: Steroid
hormone receptors in three human gastric cancer cell lines. Dig Dis
Sci. 39:2689–2694. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Karat D, Brotherick I, Shenton BK, Scott
D, Raimes SA and Griffin SM: Expression of oestrogen and
progesterone receptors in gastric cancer: a flow cytometric study.
Br J Cancer. 80:1271–1274. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chandanos E, Rubio CA, Lindblad M, et al:
Endogenous estrogen exposure in relation to distribution of
histological type and estrogen receptors in gastric adenocarcinoma.
Gastric Cancer. 11:168–174. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Matsui M, Kojima O, Uehara Y and Takahashi
T: Characterization of estrogen receptor in human gastric cancer.
Cancer. 68:305–308. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wu CW, Lui WY, P’eng FK and Chi CW:
Hormonal therapy for stomach cancer. Med Hypotheses. 39:137–139.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Machado JC, Carneiro F, Gärtner F, Ribeiro
P and Sobrinho-Simões M: Female sex hormone receptors are not
involved in gastric carcinogenesis. A biochemical and
immunohistochemical study. Eur J Cancer Prev. 3:31–37. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Singh S, Poulsom R, Wright NA, Sheppard MC
and Langman MJ: Differential expression of oestrogen receptor and
oestrogen inducible genes in gastric mucosa and cancer. Gut.
40:516–520. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Xu CY, Guo JL, Jiang ZN, et al: Prognostic
role of estrogen receptor α and estrogen receptor β in gastric
cancer. Ann Surg Oncol. 17:2503–2509. 2010.
|
|
38
|
Gan L, He J, Zhang X, et al: Expression
profile and prognostic role of sex hormone receptors in gastric
cancer. BMC Cancer. 12:5662012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kitaoka H: Sex hormone dependency and
endocrine therapy in diffuse carcinoma of the stomach]. Gan To
Kagaku Ryoho. 10:2453–2460. 1983.(In Japanese).
|
|
40
|
Matsui M, Kojima O, Kawakami S, Uehara Y
and Takahashi T: The prognosis of patients with gastric cancer
possessing sex hormone receptors. Surg Today. 22:421–425. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhao XH, Gu SZ, Liu SX and Pan BR:
Expression of estrogen receptor and estrogen receptor messenger RNA
in gastric carcinoma tissues. World J Gastroenterol. 9:665–669.
2003.PubMed/NCBI
|
|
42
|
Yokozaki H, Takekura N, Takanashi A,
Tabuchi J, Haruta R and Tahara E: Estrogen receptors in gastric
adenocarcinoma: a retrospective immunohistochemical analysis.
Virchows Arch A Pathol Anat Histopathol. 413:297–302. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wang M, Pan JY, Song GR, Chen HB, An LJ
and Qu SX: Altered expression of estrogen receptor α and β in
advanced gastric adenocarcinoma: correlation with prothymosin α and
clinicopathological parameters. Eur J Surg Oncol. 33:195–201.
2007.
|
|
44
|
Kitaoka H: Chemo-endocrine therapy of
diffuse carcinoma of the stomach and its clinical evaluation. Gan
No Rinsho. 31:1189–1194. 1985.(In Japanese).
|
|
45
|
Koullias GJ, Pratsinis CI, Korkolis DP, et
al: Brief tamoxifen pretreatment enhances the chemosensitivity of
gastric carcinoma cells to 5-fluorouracil in vitro. Anticancer Res.
23:1575–1580. 2003.PubMed/NCBI
|
|
46
|
Matsuyama S, Ohkura Y, Eguchi H, et al:
Estrogen receptor β is expressed in human stomach adenocarcinoma. J
Cancer Res Clin Oncol. 128:319–324. 2002.
|
|
47
|
Ryu WS, Kim JH, Jang YJ, et al: Expression
of estrogen receptors in gastric cancer and their clinical
significance. J Surg Oncol. 106:456–461. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Ozawa M, Ringwald M and Kemler R:
Uvomorulin-catenin complex formation is regulated by a specific
domain in the cytoplasmic region of the cell adhesion molecule.
Proc Nat Acad Sci USA. 87:4246–4250. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Conacci-Sorrell M, Simcha I, Ben-Yedidia
T, Blechman J, Savagner P and Ben-Ze’ev A: Autoregulation of
E-cadherin expression by cadherin-cadherin interactions: the roles
of β-catenin signaling, Slug, and MAPK. J Cell Biol. 163:847–857.
2003.PubMed/NCBI
|
|
50
|
Logan CY and Nusse R: The Wnt signaling
pathway in development and disease. Annu Rev Cell Dev Biol.
20:781–810. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Kanwar SS, Yu Y, Nautiyal J, Patel BB and
Majumdar AP: The Wnt/β-catenin pathway regulates growth and
maintenance of colonospheres. Mol Cancer. 9:2122010.
|
|
52
|
Hervieu V, Lepinasse F, Gouysse G, et al:
Expression of β-catenin in gastroenteropancreatic endocrine
tumours: a study of 229 cases. J Clin Pathol. 59:1300–1304.
2006.
|
|
53
|
Lin SY, Xia W, Wang JC, et al: β-catenin,
a novel prognostic marker for breast cancer: its roles in cyclin D1
expression and cancer progression. Proc Nat Acad Sci USA.
97:4262–4266. 2000.
|
|
54
|
Wong SC, Lo ES, Lee KC, Chan JK and Hsiao
WL: Prognostic and diagnostic significance of β-catenin nuclear
immunostaining in colorectal cancer. Clin Cancer Res. 10:1401–1408.
2004.
|
